Endoscopic Approaches to Upper Tract Urothelial Carcinoma

Firas G. Petros; Roger Li; Surena F. Matin

doi:10.1016/j.ucl.2017.12.009

Endoscopic Approaches to Upper Tract Urothelial Carcinoma

Firas G. Petros, Roger Li, Surena F. Matin

Urology

Research output: Contribution to journal › Review article › peer-review

24 Scopus citations

Abstract

A select group of patients with upper tract urothelial carcinoma (UTUC) may meet indications for endoscopic management. Strategies for disease management are provided, based on a comprehensive review of the data using PubMed and Medline databases and marrying this with our experience with endoscopic management of UTUC. Endoscopic management of UTUC via retrograde or antegrade approaches is a viable treatment option for appropriately selected patients with low-risk UTUC, including those with low-grade, low-volume, and solitary tumors. However, recurrence risk limits these procedures to compliant patients under a vigilant surveillance program. Efficacious adjuvant therapies are needed to reduce local recurrences.

Original language	English (US)
Pages (from-to)	267-286
Number of pages	20
Journal	Urologic Clinics of North America
Volume	45
Issue number	2
DOIs	https://doi.org/10.1016/j.ucl.2017.12.009
State	Published - May 2018

Keywords

Endoscopy
Laser
Upper-tract urothelial carcinoma
Ureteral cancer
Ureteroscopy

ASJC Scopus subject areas

Urology

Access to Document

10.1016/j.ucl.2017.12.009

Cite this

@article{984f5b103e834785beaab2d9b1da6192,

title = "Endoscopic Approaches to Upper Tract Urothelial Carcinoma",

abstract = "A select group of patients with upper tract urothelial carcinoma (UTUC) may meet indications for endoscopic management. Strategies for disease management are provided, based on a comprehensive review of the data using PubMed and Medline databases and marrying this with our experience with endoscopic management of UTUC. Endoscopic management of UTUC via retrograde or antegrade approaches is a viable treatment option for appropriately selected patients with low-risk UTUC, including those with low-grade, low-volume, and solitary tumors. However, recurrence risk limits these procedures to compliant patients under a vigilant surveillance program. Efficacious adjuvant therapies are needed to reduce local recurrences.",

keywords = "Endoscopy, Laser, Upper-tract urothelial carcinoma, Ureteral cancer, Ureteroscopy",

author = "Petros, {Firas G.} and Roger Li and Matin, {Surena F.}",

note = "Publisher Copyright: {\textcopyright} 2018 Elsevier Inc.",

year = "2018",

month = may,

doi = "10.1016/j.ucl.2017.12.009",

language = "English (US)",

volume = "45",

pages = "267--286",

journal = "Urologic Clinics of North America",

issn = "0094-0143",

publisher = "W.B. Saunders Ltd",

number = "2",

}

TY - JOUR

T1 - Endoscopic Approaches to Upper Tract Urothelial Carcinoma

AU - Petros, Firas G.

AU - Li, Roger

AU - Matin, Surena F.

PY - 2018/5

Y1 - 2018/5

N2 - A select group of patients with upper tract urothelial carcinoma (UTUC) may meet indications for endoscopic management. Strategies for disease management are provided, based on a comprehensive review of the data using PubMed and Medline databases and marrying this with our experience with endoscopic management of UTUC. Endoscopic management of UTUC via retrograde or antegrade approaches is a viable treatment option for appropriately selected patients with low-risk UTUC, including those with low-grade, low-volume, and solitary tumors. However, recurrence risk limits these procedures to compliant patients under a vigilant surveillance program. Efficacious adjuvant therapies are needed to reduce local recurrences.

AB - A select group of patients with upper tract urothelial carcinoma (UTUC) may meet indications for endoscopic management. Strategies for disease management are provided, based on a comprehensive review of the data using PubMed and Medline databases and marrying this with our experience with endoscopic management of UTUC. Endoscopic management of UTUC via retrograde or antegrade approaches is a viable treatment option for appropriately selected patients with low-risk UTUC, including those with low-grade, low-volume, and solitary tumors. However, recurrence risk limits these procedures to compliant patients under a vigilant surveillance program. Efficacious adjuvant therapies are needed to reduce local recurrences.

KW - Endoscopy

KW - Laser

KW - Upper-tract urothelial carcinoma

KW - Ureteral cancer

KW - Ureteroscopy

UR - http://www.scopus.com/inward/record.url?scp=85042193944&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042193944&partnerID=8YFLogxK

U2 - 10.1016/j.ucl.2017.12.009

DO - 10.1016/j.ucl.2017.12.009

M3 - Review article

C2 - 29650142

AN - SCOPUS:85042193944

SN - 0094-0143

VL - 45

SP - 267

EP - 286

JO - Urologic Clinics of North America

JF - Urologic Clinics of North America

IS - 2

ER -

Endoscopic Approaches to Upper Tract Urothelial Carcinoma

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this